A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy.

Kadkhodazadeh M, Sabri H, Pakjoo M, Sadeghi-Mohammadi S, Barkhordari F, Bagherian M, Sarrami-Forooshani R.

Open source

DOI: 10.1038/s41598-026-56032-4
Published: 2026-06-17
Container: Sci Rep
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-56032-4,
  title = {A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy.},
  author = {Kadkhodazadeh M and  Sabri H and  Pakjoo M and  Sadeghi-Mohammadi S and  Barkhordari F and  Bagherian M and  Sarrami-Forooshani R.},
  year = {2026},
  journal = {Sci Rep},
  doi = {10.1038/s41598-026-56032-4},
  url = {https://doi.org/10.1038/s41598-026-56032-4}
}

RIS

TY  - JOUR
TI  - A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy.
AU  - Kadkhodazadeh M
AU  -  Sabri H
AU  -  Pakjoo M
AU  -  Sadeghi-Mohammadi S
AU  -  Barkhordari F
AU  -  Bagherian M
AU  -  Sarrami-Forooshani R.
PY  - 2026
JO  - Sci Rep
DO  - 10.1038/s41598-026-56032-4
UR  - https://doi.org/10.1038/s41598-026-56032-4
ER  -

APA

M, K., H, S., M, P., S, S., F, B., M, B., & R., S. (2026). A promising combination strategy: oncolytic adenovirus (ΔE1B-55 K/E3) and arsenic trioxide for potent cancer therapy.. Sci Rep. https://doi.org/10.1038/s41598-026-56032-4

Source records

europe-pmc · retrieved 2026-09-25T20:03:08.274Z
doaj · retrieved 2026-09-25T20:03:08.284Z